Push the stock share to 0% and the deal becomes more accretive, because debt at 6% pre-tax is cheaper than equity at a 20× multiple. That is the whole trick, and it is why accretion is a financing statement, not a valuation one. The real test is whether the price beats the target's standalone value — that is a DCF question, not an EPS one.
The idea behind it
This calculator belongs to Corporate Actions, where the mechanism it computes is explained step by step, with the formula, what each input means and where the simple model stops being right. Everything is computed in your browser; nothing you type is sent anywhere.
Information and education only. Every page, figure and
calculator on this site exists to explain how financial instruments work. Nothing here is
investment, tax or legal advice, a recommendation, or a valuation you can rely on.Full disclaimer